Stay Informed

Sign up for news & alerts

Already signed up?
Login here
What Can I Do?


Get Help
Need alcohol or drug help for yourself or someone else? GET HELP
Resources
Resources
Find useful publications, online documents & more.


DrugScreening.org


 

Early Use of ADHD Drugs Could Be Risk Factor for Drug Abuse
June 21, 2007

Email
Email
Print
Print
SubscribeSubscribe
Research Summary

Brookhaven National Laboratory researchers say that children who start taking prescription medications for attention-deficit hyperactivity disorder (ADHD) young may be at higher risk for alcohol and other drug abuse later in life.

A study showed that adolescent rats given methylphenidate -- a stimulant commonly found in ADHD drugs -- had fewer dopamine receptors in their brains, which could increase their risk for drug abuse. Rats receiving the ADHD drugs also were less likely to self-administer cocaine.

"Our study shows that the brain's reward pathways are definitely influenced by methylphenidate," said lead study author Panayotis Thanos. "But the brain chemistry changes we observed suggest that the developmental stage at which treatment begins and the duration of treatment are important variables that need further study."

The study appeared online June 5, 2007 in the journal Pharmacology, Biochemistry and Behavior.

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (guidelines):

Name:

Comment:
(limit 200
words)

Enter this word
(help):
Change

GUIDELINES:
Comments are meant for thoughtful public discussion of the article published above. Therefore:

  1. Keep it clean, courteous, focused, and on-topic.

  2. Do not post personal requests for help (see resources).

  3. Proof your comments carefully for spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

  4. Deceptive, slanderous and commercially-motivated comments are prohibited.

We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.